{"database":"biostudies-arrayexpress","file_versions":[],"scores":null,"additional":{"submitter":["Antonio Rinaldi"],"organism":["Homo sapiens"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/E-MTAB-15146"],"description":["RNA-sequencing was performed on H1299, HEK293T and CHO-K1 transfected with plasmids expressing EGFP and mKate in an open loop circuit (OL), w/wo compound supplementation, or with iFFL circuit.mKate has target sites for miRNAs highly expressed in the different cell lines (miRNA31 for H1299, miRNA221 for HEK293T and miRNA21 for CHO-K1)"],"repository":["biostudies-arrayexpress"],"sample_protocol":["Sample Treatment - Transfections were carried out in 24-well plate for flow cytometry analysis.   H1299 cells were transfected with Lipofectamine® 3000 according to manufacturer’s instructions and 300 ng of total DNA in 24-well plates. CHO and HEK293 were transfected with PEI transfection reagent with 300 ng of total DNA in 24-well plates. All cells were plated approximately 24h before transfection at 70000 to 80000 cells per well in 24-wells plates. At the moment of transfection, cells were put in starvation conditions, meaning in poor media for the first 24h. DNA was diluted in Opti-MEM reduced serum media (Gibco), before being mixed and incubated for 25 minutes prior to addition to the cells. All drugs were added 4h after transfection.  Modified-RNAs (modRNA) were transfected using Lipofectamine® 3000 protocol under modified conditions in which no P3000 reagent was used. RNA was first diluted in Opti-MEM reduced serum media (Gibco) and it was then mixed with diluted Lipofectamine reagent as manufacturer’s instructions. The mix was incubated for 7 minutes prior to addition to the cells. The fast-forward protocol was used by seeding 120000 cells per well in 24-wells plates at the moment of transfection.","Sequencing - Samples were processed with Illumina Novaseq6000","Library Construction - Libraries were prepared by Total RNAseq with ribo0 plus (Illumina)"],"figure_sub":["Organization","MINSEQE Score","Assays and Data","MAGE-TAB Files"],"data_protocol":["Data Transformation - Sequence reads were trimmed using bbduk software to remove adapter sequences, poly-A tails and low-quality end bases. Alignment was performed with STAR on the Homo sapiens reference (hg38) provided by UCSC Genome Browser. The expression level of genes was determined with htseq-count using the Gencode/Ensembl gene model"],"omics_type":["Metabolomics","Unknown","Transcriptomics","Genomics","Proteomics"],"instrument_platform":["Illumina NovaSeq 6000"],"study_type":["RNA-seq of coding RNA"],"species":["Homo sapiens"],"pubmed_authors":["Antonio Rinaldi"],"additional_accession":[]},"is_claimable":false,"name":"Transcriptomic analysis of H1299, HEK293T and CHO-K1 treated with Filgotinib","description":"RNA-sequencing was performed on H1299, HEK293T and CHO-K1 transfected with plasmids expressing EGFP and mKate in an open loop circuit (OL), w/wo compound supplementation, or with iFFL circuit.mKate has target sites for miRNAs highly expressed in the different cell lines (miRNA31 for H1299, miRNA221 for HEK293T and miRNA21 for CHO-K1)","dates":{"release":"2025-07-24T00:00:00Z","modification":"2025-07-24T07:41:28.408Z","creation":"2025-05-19T09:56:39.516Z"},"accession":"E-MTAB-15146","cross_references":{"ENA":["ERP172710"],"Biostudies":["E-MTAB-14355"],"EFO":["EFO_0004170","EFO_0003816","EFO_0003738","EFO_0004184","EFO_0003969"]}}